[Form 4] Intercontinental Exchange Inc. Insider Trading Activity
Rhea-AI Filing Summary
Insider sales under pre-set plan: Director Judith A. Sprieser reported three separate dispositions of Intercontinental Exchange (ICE) common stock executed under a Rule 10b5-1 trading plan that became effective June 5, 2025. The reported transactions sold 1,500, 1,100 and 300 shares at reported price ranges between $173.43 and $175.88 per share, reducing her direct holdings to an aggregate 18,169 shares (which consists of 16,695 common shares and 1,474 restricted stock units).
The restricted stock units will vest on May 16, 2026. The filing states the issuer can provide detailed per-trade price information on request, and the transactions were reported by an attorney-in-fact on the reporting person’s behalf.
Positive
- None.
Negative
- None.
Insights
TL;DR: Director sold a small portion of holdings via an approved 10b5-1 plan; transactions appear routine and pre-scheduled.
The aggregate sale of 2,900 shares represents a partial, orderly disposition executed under a Rule 10b5-1 plan approved June 5, 2025. Reported price bands span roughly $173.43 to $175.88, and the filing discloses that the director retains 16,695 common shares plus 1,474 RSUs. From a market-impact perspective, these transactions are procedural and lack indications of ad hoc opportunistic timing because they were executed pursuant to a documented trading plan. Impact to ICE equity outstanding and liquidity is immaterial based on reported volumes here.
TL;DR: The sale follows an approved 10b5-1 plan and includes RSU disclosure, reflecting proper governance and disclosure practices.
The filing clearly indicates the trades were made pursuant to a Rule 10b5-1 trading plan, which provides an affirmative defense to insider trading allegations when properly structured. The report also separates common shares and restricted stock units and states the RSU vesting date of May 16, 2026, satisfying transparency expectations for insider reporting. The use of an attorney-in-fact for execution and the issuer's offer to provide per-trade pricing upon request are consistent with thorough compliance and disclosure norms.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 1,500 | $174.0653 | $261K |
| Sale | Common Stock | 1,100 | $174.7844 | $192K |
| Sale | Common Stock | 300 | $175.75 | $53K |
Footnotes (1)
- This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of June 5, 2025. The price range for the aggregate amount sold by the direct holder is $173.43 - $174.42. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. The price range for the aggregate amount sold by the direct holder is $174.44 - $175.34. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. The price range for the aggregate amount sold by the direct holder is $175.49 - $175.88. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. The common stock number referred in Table I is an aggregate number and represents 16,695 shares of common stock and 1,474 restricted stock units of the Issuer. The restricted stock units vest on the one-year anniversary of the grant date, which is May 16, 2026.